Cargando…
The genetic association of the transcription factor NPAT with glycemic response to metformin involves regulation of fuel selection
The biguanide, metformin, is the first-choice therapeutic agent for type-2 diabetes, although the mechanisms that underpin metformin clinical efficacy remain the subject of much debate, partly due to the considerable variation in patient response to metformin. Identification of poor responders by ge...
Autores principales: | Chen, Changwei, Gallagher, Jennifer R., Tarlton, Jamie, van Aalten, Lidy, Bray, Susan E., Ashford, Michael L. J., McCrimmon, Rory J., Pearson, Ewan R., McNeilly, Alison D., Sutherland, Calum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248654/ https://www.ncbi.nlm.nih.gov/pubmed/34197485 http://dx.doi.org/10.1371/journal.pone.0253533 |
Ejemplares similares
-
Reducing Glut2 throughout the body does not result in cognitive behaviour differences in aged male mice
por: Morrice, Nicola, et al.
Publicado: (2020) -
Metformin increases the uptake of glucose into the gut from the circulation in high-fat diet-fed male mice, which is enhanced by a reduction in whole-body Slc2a2 expression
por: Morrice, Nicola, et al.
Publicado: (2023) -
Central deficiency of IL-6Ra in mice impairs glucose-stimulated insulin secretion
por: McNeilly, Alison D., et al.
Publicado: (2022) -
Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab
por: McNeilly, Alison D., et al.
Publicado: (2018) -
Recruitment, Retainment, and Biomarkers of Response; A Pilot Trial of Lithium in Humans With Mild Cognitive Impairment
por: Duthie, Ashleigh, et al.
Publicado: (2019)